Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burns | 33 | 2020 | 1902 | 2.960 |
Why?
|
Wounds and Injuries | 20 | 2020 | 2513 | 2.170 |
Why?
|
T-Lymphocytes, Regulatory | 15 | 2022 | 3114 | 1.520 |
Why?
|
Mesenchymal Stem Cell Transplantation | 4 | 2023 | 504 | 1.290 |
Why?
|
Immune System | 6 | 2015 | 800 | 1.260 |
Why?
|
CD4-Positive T-Lymphocytes | 23 | 2024 | 4410 | 1.230 |
Why?
|
Spleen | 20 | 2020 | 2295 | 1.100 |
Why?
|
Leukocytes, Mononuclear | 8 | 2023 | 1852 | 1.090 |
Why?
|
Mesenchymal Stem Cells | 6 | 2024 | 1663 | 1.070 |
Why?
|
Lymphocyte Activation | 22 | 2021 | 5503 | 1.060 |
Why?
|
Cytokines | 24 | 2022 | 7438 | 0.970 |
Why?
|
Inflammasomes | 4 | 2022 | 541 | 0.970 |
Why?
|
Sepsis | 12 | 2024 | 2604 | 0.960 |
Why?
|
Pneumonia, Pneumococcal | 2 | 2015 | 133 | 0.930 |
Why?
|
T-Lymphocytes | 19 | 2021 | 10264 | 0.750 |
Why?
|
Flow Cytometry | 19 | 2022 | 5890 | 0.710 |
Why?
|
Receptors, Cell Surface | 6 | 2011 | 2815 | 0.700 |
Why?
|
Killer Cells, Natural | 2 | 2020 | 2210 | 0.700 |
Why?
|
Immunophenotyping | 11 | 2023 | 1867 | 0.670 |
Why?
|
Th1 Cells | 16 | 2021 | 1040 | 0.670 |
Why?
|
Th2 Cells | 12 | 2016 | 1078 | 0.640 |
Why?
|
Superantigens | 4 | 2004 | 124 | 0.640 |
Why?
|
Systemic Inflammatory Response Syndrome | 5 | 2020 | 621 | 0.630 |
Why?
|
Mice | 81 | 2024 | 81889 | 0.620 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 812 | 0.600 |
Why?
|
Wound Infection | 2 | 2019 | 244 | 0.590 |
Why?
|
CD8-Positive T-Lymphocytes | 13 | 2023 | 4652 | 0.580 |
Why?
|
Interleukin-10 | 11 | 2012 | 1182 | 0.540 |
Why?
|
Enterotoxins | 6 | 2011 | 366 | 0.540 |
Why?
|
T-Lymphocyte Subsets | 9 | 2019 | 1814 | 0.540 |
Why?
|
Neutrophils | 13 | 2024 | 3782 | 0.530 |
Why?
|
Animals | 97 | 2024 | 168930 | 0.520 |
Why?
|
Monocytes | 7 | 2019 | 2600 | 0.510 |
Why?
|
Adjuvants, Immunologic | 2 | 2015 | 996 | 0.500 |
Why?
|
Oligodeoxyribonucleotides | 3 | 2015 | 705 | 0.490 |
Why?
|
Neutropenia | 1 | 2020 | 894 | 0.490 |
Why?
|
Caspase 1 | 2 | 2014 | 227 | 0.470 |
Why?
|
Interleukin-1 | 9 | 2005 | 1251 | 0.470 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 2 | 2011 | 69 | 0.460 |
Why?
|
Membrane Glycoproteins | 7 | 2011 | 3702 | 0.460 |
Why?
|
Immunologic Memory | 2 | 2020 | 1377 | 0.450 |
Why?
|
Macrophages | 13 | 2024 | 5783 | 0.450 |
Why?
|
Lymph Nodes | 9 | 2020 | 3468 | 0.440 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 354 | 0.430 |
Why?
|
Interferon-gamma | 17 | 2022 | 3158 | 0.420 |
Why?
|
Breeding | 1 | 2012 | 49 | 0.420 |
Why?
|
Lupus Nephritis | 3 | 2022 | 324 | 0.410 |
Why?
|
Immunity, Innate | 11 | 2015 | 3077 | 0.400 |
Why?
|
Phagocytosis | 8 | 2024 | 1527 | 0.380 |
Why?
|
Mice, Inbred C57BL | 28 | 2023 | 22352 | 0.370 |
Why?
|
Interleukin-2 | 13 | 2015 | 1895 | 0.370 |
Why?
|
Arthritis, Rheumatoid | 8 | 2021 | 3788 | 0.370 |
Why?
|
T-Lymphocytes, Helper-Inducer | 6 | 2024 | 975 | 0.370 |
Why?
|
Disease Models, Animal | 22 | 2024 | 18330 | 0.370 |
Why?
|
Lymphocytes | 5 | 2020 | 2605 | 0.360 |
Why?
|
Inflammation | 14 | 2021 | 10860 | 0.350 |
Why?
|
Shock | 1 | 2012 | 316 | 0.340 |
Why?
|
Interferon Type I | 2 | 2024 | 568 | 0.340 |
Why?
|
Signal Transduction | 12 | 2019 | 23619 | 0.340 |
Why?
|
Receptors, Interleukin-2 | 3 | 2006 | 565 | 0.330 |
Why?
|
HMGA1a Protein | 2 | 2021 | 63 | 0.330 |
Why?
|
Dendritic Cells | 6 | 2012 | 2747 | 0.320 |
Why?
|
Leukocytes | 7 | 2022 | 2035 | 0.320 |
Why?
|
Enzyme Activation | 4 | 2014 | 3587 | 0.310 |
Why?
|
Radiation Injuries | 2 | 2014 | 1194 | 0.310 |
Why?
|
Lipopolysaccharides | 12 | 2021 | 2214 | 0.310 |
Why?
|
Cell Proliferation | 11 | 2023 | 10445 | 0.300 |
Why?
|
Forkhead Transcription Factors | 3 | 2011 | 1627 | 0.290 |
Why?
|
Antigen Presentation | 5 | 2010 | 1250 | 0.290 |
Why?
|
Gene Expression Regulation | 12 | 2019 | 11920 | 0.280 |
Why?
|
Synovial Membrane | 3 | 2019 | 536 | 0.280 |
Why?
|
Interleukins | 4 | 2022 | 795 | 0.280 |
Why?
|
Tumor Necrosis Factor-alpha | 13 | 2018 | 4349 | 0.270 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2023 | 1642 | 0.270 |
Why?
|
Lupus Erythematosus, Systemic | 4 | 2024 | 2160 | 0.270 |
Why?
|
Chemokine CXCL13 | 2 | 2024 | 62 | 0.260 |
Why?
|
Immunity | 4 | 2020 | 1002 | 0.260 |
Why?
|
Ovalbumin | 3 | 2003 | 677 | 0.260 |
Why?
|
Hemorrhage | 4 | 2019 | 3464 | 0.250 |
Why?
|
Escherichia coli Infections | 2 | 2018 | 518 | 0.250 |
Why?
|
Antibody Formation | 5 | 2020 | 1392 | 0.240 |
Why?
|
B-Lymphocytes | 5 | 2019 | 4784 | 0.240 |
Why?
|
Toll-Like Receptors | 5 | 2009 | 582 | 0.240 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2012 | 1023 | 0.240 |
Why?
|
Male | 64 | 2024 | 364142 | 0.240 |
Why?
|
Synovial Fluid | 3 | 2022 | 391 | 0.230 |
Why?
|
Phenotype | 6 | 2022 | 16724 | 0.230 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2011 | 2571 | 0.220 |
Why?
|
Mice, Transgenic | 10 | 2021 | 9547 | 0.220 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2024 | 287 | 0.220 |
Why?
|
Mice, Inbred BALB C | 11 | 2021 | 6222 | 0.210 |
Why?
|
Adoptive Transfer | 4 | 2021 | 828 | 0.210 |
Why?
|
Keratitis | 2 | 2016 | 241 | 0.200 |
Why?
|
Paracrine Communication | 1 | 2024 | 277 | 0.200 |
Why?
|
Macrophage Activation Syndrome | 1 | 2023 | 124 | 0.200 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 615 | 0.200 |
Why?
|
Culture Media, Conditioned | 1 | 2023 | 520 | 0.200 |
Why?
|
Sialoglycoproteins | 2 | 1994 | 316 | 0.200 |
Why?
|
Respiratory Burst | 2 | 2023 | 110 | 0.200 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2024 | 221 | 0.200 |
Why?
|
Inflammation Mediators | 3 | 2008 | 1889 | 0.190 |
Why?
|
Toll-Like Receptor 4 | 5 | 2008 | 588 | 0.190 |
Why?
|
Antigens | 3 | 2003 | 1441 | 0.190 |
Why?
|
NF-kappa B | 3 | 2018 | 2493 | 0.190 |
Why?
|
Chemokine CXCL12 | 2 | 2021 | 457 | 0.190 |
Why?
|
Purines | 2 | 2022 | 615 | 0.190 |
Why?
|
Gene Expression Profiling | 9 | 2024 | 9525 | 0.190 |
Why?
|
Interleukin-4 | 8 | 1998 | 1155 | 0.180 |
Why?
|
Genes, Dominant | 2 | 2021 | 855 | 0.180 |
Why?
|
Carbon Monoxide | 1 | 2024 | 560 | 0.180 |
Why?
|
Shock, Septic | 2 | 2005 | 772 | 0.180 |
Why?
|
Up-Regulation | 4 | 2012 | 4142 | 0.170 |
Why?
|
Interleukin-17 | 2 | 2017 | 923 | 0.170 |
Why?
|
Mice, Inbred A | 5 | 2001 | 244 | 0.170 |
Why?
|
Cells, Cultured | 19 | 2021 | 18984 | 0.170 |
Why?
|
Multiple Trauma | 1 | 2023 | 369 | 0.170 |
Why?
|
Isoquinolines | 1 | 2021 | 350 | 0.170 |
Why?
|
Histocompatibility Antigens Class II | 3 | 2020 | 1442 | 0.170 |
Why?
|
Asthma, Aspirin-Induced | 1 | 2023 | 204 | 0.170 |
Why?
|
Epitopes | 2 | 2020 | 2526 | 0.170 |
Why?
|
Trophoblasts | 1 | 2021 | 223 | 0.170 |
Why?
|
Mice, Knockout | 12 | 2021 | 14471 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-maf | 1 | 2019 | 69 | 0.170 |
Why?
|
Aortic Diseases | 2 | 2016 | 741 | 0.170 |
Why?
|
Transcription Factor AP-1 | 1 | 2001 | 321 | 0.170 |
Why?
|
Epitope Mapping | 1 | 2020 | 301 | 0.160 |
Why?
|
Technology | 1 | 2022 | 296 | 0.160 |
Why?
|
Lung Injury | 2 | 2020 | 432 | 0.160 |
Why?
|
Autoimmunity | 3 | 2023 | 1358 | 0.160 |
Why?
|
Arthritis, Experimental | 1 | 2021 | 293 | 0.160 |
Why?
|
Antigen-Presenting Cells | 5 | 2012 | 960 | 0.160 |
Why?
|
Cytomegalovirus | 1 | 2023 | 754 | 0.160 |
Why?
|
Homeodomain Proteins | 3 | 2015 | 2430 | 0.160 |
Why?
|
Public-Private Sector Partnerships | 1 | 2020 | 123 | 0.160 |
Why?
|
Gene Regulatory Networks | 1 | 2007 | 1751 | 0.160 |
Why?
|
Multiple Organ Failure | 1 | 2001 | 389 | 0.160 |
Why?
|
Fibroblasts | 5 | 2019 | 4166 | 0.160 |
Why?
|
Receptors, Purinergic P2X4 | 1 | 2018 | 21 | 0.150 |
Why?
|
Immunoglobulin G | 3 | 2020 | 4559 | 0.150 |
Why?
|
Receptors, LDL | 3 | 2016 | 492 | 0.150 |
Why?
|
Immunotherapy | 4 | 2022 | 4747 | 0.150 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2020 | 329 | 0.150 |
Why?
|
Cell Polarity | 1 | 2021 | 637 | 0.150 |
Why?
|
Tumor Escape | 1 | 2021 | 371 | 0.150 |
Why?
|
Nasal Polyps | 1 | 2023 | 412 | 0.150 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 1144 | 0.150 |
Why?
|
Interleukin-1beta | 2 | 2021 | 1026 | 0.150 |
Why?
|
Interleukin-12 | 6 | 2000 | 581 | 0.150 |
Why?
|
Hyperoxia | 1 | 2020 | 259 | 0.150 |
Why?
|
Acute Lung Injury | 1 | 2021 | 377 | 0.140 |
Why?
|
Autocrine Communication | 1 | 2018 | 168 | 0.140 |
Why?
|
Humans | 67 | 2024 | 766766 | 0.140 |
Why?
|
Transgenes | 1 | 2021 | 1014 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 838 | 0.140 |
Why?
|
Injury Severity Score | 2 | 2017 | 1049 | 0.140 |
Why?
|
CD4-CD8 Ratio | 1 | 2016 | 114 | 0.140 |
Why?
|
MicroRNAs | 2 | 2024 | 3792 | 0.140 |
Why?
|
Atherosclerosis | 4 | 2016 | 3420 | 0.140 |
Why?
|
Time Factors | 10 | 2020 | 40149 | 0.140 |
Why?
|
Plasma | 1 | 2020 | 583 | 0.130 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2015 | 306 | 0.130 |
Why?
|
Antibodies, Monoclonal | 3 | 2016 | 9244 | 0.130 |
Why?
|
Protein Kinase C | 2 | 2011 | 1206 | 0.130 |
Why?
|
Pulmonary Alveoli | 1 | 2019 | 665 | 0.130 |
Why?
|
Chemokine CCL2 | 2 | 2017 | 604 | 0.130 |
Why?
|
Arthritis | 1 | 2022 | 684 | 0.130 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2020 | 792 | 0.130 |
Why?
|
Autophagy | 1 | 2024 | 1346 | 0.130 |
Why?
|
Nitric Oxide | 1 | 2005 | 2141 | 0.130 |
Why?
|
Oncolytic Virotherapy | 1 | 2022 | 520 | 0.130 |
Why?
|
Glioblastoma | 2 | 2022 | 3458 | 0.130 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2010 | 3796 | 0.130 |
Why?
|
Receptors, Chemokine | 2 | 2017 | 652 | 0.130 |
Why?
|
Receptors, Interleukin-1 | 2 | 1994 | 260 | 0.130 |
Why?
|
Rhinitis | 1 | 2023 | 753 | 0.130 |
Why?
|
Eye Infections, Fungal | 1 | 2016 | 99 | 0.130 |
Why?
|
Injections, Intraperitoneal | 2 | 2008 | 410 | 0.130 |
Why?
|
Acetylglucosamine | 1 | 2016 | 188 | 0.120 |
Why?
|
Incineration | 1 | 2014 | 21 | 0.120 |
Why?
|
Recycling | 1 | 2014 | 16 | 0.120 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1995 | 222 | 0.120 |
Why?
|
Interleukin-6 | 5 | 2021 | 3227 | 0.120 |
Why?
|
Immunity, Cellular | 2 | 2016 | 1560 | 0.120 |
Why?
|
Antilymphocyte Serum | 1 | 2016 | 492 | 0.120 |
Why?
|
Adenosine Triphosphate | 2 | 2018 | 2001 | 0.120 |
Why?
|
Polymerase Chain Reaction | 5 | 2007 | 6066 | 0.110 |
Why?
|
Sinusitis | 1 | 2023 | 997 | 0.110 |
Why?
|
CLOCK Proteins | 1 | 2014 | 89 | 0.110 |
Why?
|
Cattle | 6 | 1994 | 3815 | 0.110 |
Why?
|
Neutrophil Activation | 2 | 2021 | 180 | 0.110 |
Why?
|
Toll-Like Receptor 2 | 3 | 2008 | 347 | 0.110 |
Why?
|
Dexamethasone | 1 | 2022 | 1962 | 0.110 |
Why?
|
Cell Death | 2 | 2021 | 1676 | 0.110 |
Why?
|
Fibrosarcoma | 2 | 2010 | 313 | 0.110 |
Why?
|
Th17 Cells | 1 | 2020 | 790 | 0.110 |
Why?
|
Endotoxins | 2 | 2014 | 519 | 0.110 |
Why?
|
Lung | 7 | 2023 | 10067 | 0.110 |
Why?
|
Drug Industry | 1 | 2020 | 791 | 0.110 |
Why?
|
Cell Differentiation | 9 | 2024 | 11651 | 0.110 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2014 | 877 | 0.100 |
Why?
|
Tears | 1 | 2014 | 254 | 0.100 |
Why?
|
Antibodies | 2 | 2023 | 2421 | 0.100 |
Why?
|
Female | 34 | 2024 | 396520 | 0.100 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 938 | 0.100 |
Why?
|
Conservation of Natural Resources | 1 | 2014 | 209 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2022 | 2158 | 0.100 |
Why?
|
Whole-Body Irradiation | 1 | 2012 | 438 | 0.100 |
Why?
|
Eye Infections, Bacterial | 1 | 2014 | 239 | 0.090 |
Why?
|
Autoimmune Diseases | 1 | 2023 | 2254 | 0.090 |
Why?
|
Gamma Rays | 1 | 2012 | 324 | 0.090 |
Why?
|
Antigens, Surface | 2 | 2011 | 1617 | 0.090 |
Why?
|
Myelodysplastic Syndromes | 1 | 2021 | 1404 | 0.090 |
Why?
|
Cell Separation | 3 | 2019 | 1718 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2020 | 2060 | 0.090 |
Why?
|
Hematopoietic Stem Cells | 1 | 2023 | 3408 | 0.090 |
Why?
|
Lymphocyte Depletion | 3 | 2011 | 606 | 0.090 |
Why?
|
Peptide Fragments | 1 | 2003 | 5143 | 0.090 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 3 | 2021 | 299 | 0.090 |
Why?
|
Cornea | 2 | 2016 | 1316 | 0.090 |
Why?
|
Case-Control Studies | 4 | 2021 | 22248 | 0.090 |
Why?
|
Heme Oxygenase-1 | 1 | 2013 | 364 | 0.090 |
Why?
|
Zinc | 1 | 2014 | 675 | 0.090 |
Why?
|
Streptococcus pneumoniae | 1 | 2015 | 764 | 0.090 |
Why?
|
Databases, Genetic | 2 | 2014 | 1756 | 0.090 |
Why?
|
Proteomics | 1 | 2023 | 3914 | 0.080 |
Why?
|
Brain Neoplasms | 2 | 2022 | 9101 | 0.080 |
Why?
|
HLA-DR Antigens | 2 | 2023 | 609 | 0.080 |
Why?
|
Interleukin-5 | 2 | 2023 | 268 | 0.080 |
Why?
|
Cell Survival | 2 | 2021 | 5748 | 0.080 |
Why?
|
Middle Aged | 17 | 2021 | 223257 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2783 | 0.080 |
Why?
|
Cell Movement | 2 | 2018 | 5199 | 0.080 |
Why?
|
Gene Expression | 5 | 2019 | 7585 | 0.080 |
Why?
|
Antibodies, Viral | 1 | 2020 | 3212 | 0.080 |
Why?
|
Lung Diseases | 1 | 2019 | 1941 | 0.080 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2011 | 414 | 0.080 |
Why?
|
NFATC Transcription Factors | 1 | 2011 | 392 | 0.080 |
Why?
|
Uric Acid | 1 | 2014 | 809 | 0.080 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1969 | 0.080 |
Why?
|
Antibodies, Blocking | 2 | 2011 | 250 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2015 | 2198 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 4570 | 0.080 |
Why?
|
Myeloid Cells | 3 | 2020 | 838 | 0.080 |
Why?
|
Lethal Dose 50 | 1 | 2008 | 71 | 0.080 |
Why?
|
Receptors, CXCR5 | 2 | 2019 | 88 | 0.080 |
Why?
|
Single-Cell Analysis | 4 | 2021 | 2534 | 0.080 |
Why?
|
Models, Immunological | 1 | 2010 | 517 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2012 | 750 | 0.070 |
Why?
|
Lymphocyte Antigen 96 | 2 | 2008 | 21 | 0.070 |
Why?
|
Tumor Microenvironment | 4 | 2022 | 3944 | 0.070 |
Why?
|
Survival Rate | 5 | 2013 | 12825 | 0.070 |
Why?
|
Kidney | 2 | 2022 | 7074 | 0.070 |
Why?
|
Adaptive Immunity | 1 | 2012 | 734 | 0.070 |
Why?
|
Ascitic Fluid | 1 | 2008 | 189 | 0.070 |
Why?
|
Cecum | 3 | 2013 | 231 | 0.070 |
Why?
|
Membrane Proteins | 2 | 2016 | 7868 | 0.070 |
Why?
|
Cell Communication | 3 | 2019 | 1660 | 0.070 |
Why?
|
Head and Neck Neoplasms | 1 | 2022 | 2929 | 0.070 |
Why?
|
Nutritional Requirements | 1 | 1989 | 276 | 0.070 |
Why?
|
Haemophilus | 1 | 1987 | 28 | 0.070 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 2846 | 0.070 |
Why?
|
Isoenzymes | 1 | 2011 | 1688 | 0.070 |
Why?
|
Cell Division | 3 | 2003 | 4474 | 0.070 |
Why?
|
Immune Tolerance | 3 | 2020 | 2325 | 0.070 |
Why?
|
Immunity, Active | 1 | 2005 | 58 | 0.060 |
Why?
|
Bacteremia | 1 | 2013 | 987 | 0.060 |
Why?
|
Receptors, Immunologic | 1 | 1992 | 1418 | 0.060 |
Why?
|
Adult | 17 | 2021 | 223307 | 0.060 |
Why?
|
Selenium | 1 | 1989 | 418 | 0.060 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1150 | 0.060 |
Why?
|
Pneumonia | 2 | 2014 | 2159 | 0.060 |
Why?
|
Disease Susceptibility | 2 | 2020 | 1791 | 0.060 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2021 | 755 | 0.060 |
Why?
|
Environmental Pollutants | 1 | 2014 | 1294 | 0.060 |
Why?
|
Lung Diseases, Interstitial | 1 | 2014 | 939 | 0.060 |
Why?
|
Opportunistic Infections | 1 | 2008 | 376 | 0.060 |
Why?
|
Macrophage Activation | 1 | 2008 | 553 | 0.060 |
Why?
|
Mitochondria | 1 | 2018 | 3677 | 0.060 |
Why?
|
MyoD Protein | 1 | 2005 | 143 | 0.060 |
Why?
|
Abdominal Injuries | 1 | 2008 | 362 | 0.060 |
Why?
|
Shock, Traumatic | 1 | 2004 | 22 | 0.060 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2006 | 897 | 0.060 |
Why?
|
Molecular Sequence Data | 6 | 2003 | 17608 | 0.060 |
Why?
|
Adaptation, Physiological | 2 | 2003 | 1313 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2021 | 4904 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2017 | 3799 | 0.060 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1105 | 0.060 |
Why?
|
Coculture Techniques | 2 | 2019 | 1337 | 0.060 |
Why?
|
RNA, Messenger | 3 | 2014 | 12791 | 0.060 |
Why?
|
Antibody-Producing Cells | 1 | 2023 | 140 | 0.050 |
Why?
|
Blood Loss, Surgical | 1 | 2007 | 642 | 0.050 |
Why?
|
Chemokine CCL4 | 1 | 2023 | 126 | 0.050 |
Why?
|
Binding, Competitive | 2 | 1995 | 1141 | 0.050 |
Why?
|
Antigens, CD | 3 | 2006 | 4032 | 0.050 |
Why?
|
Peptidoglycan | 1 | 2005 | 246 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2008 | 1244 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2014 | 2593 | 0.050 |
Why?
|
Interleukin-15 | 1 | 2023 | 186 | 0.050 |
Why?
|
Mice, Inbred Strains | 3 | 2003 | 1767 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2021 | 2039 | 0.050 |
Why?
|
Survival Analysis | 3 | 2012 | 10100 | 0.050 |
Why?
|
Transcription, Genetic | 4 | 2001 | 7609 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15908 | 0.050 |
Why?
|
Antigens, Ly | 1 | 2003 | 297 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 911 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2006 | 637 | 0.050 |
Why?
|
Metabolism | 1 | 2003 | 193 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4924 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2023 | 457 | 0.050 |
Why?
|
Concanavalin A | 1 | 2001 | 189 | 0.050 |
Why?
|
Transforming Growth Factor beta | 2 | 2006 | 1996 | 0.050 |
Why?
|
Annual Reports as Topic | 1 | 2020 | 36 | 0.050 |
Why?
|
Homeostasis | 1 | 2012 | 3342 | 0.050 |
Why?
|
HL-60 Cells | 1 | 2021 | 365 | 0.040 |
Why?
|
MAP Kinase Signaling System | 1 | 2008 | 1491 | 0.040 |
Why?
|
Lipoproteins, LDL | 2 | 2016 | 642 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 630 | 0.040 |
Why?
|
Kidney Function Tests | 1 | 2022 | 685 | 0.040 |
Why?
|
Vidarabine | 1 | 2021 | 342 | 0.040 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2000 | 159 | 0.040 |
Why?
|
Quinazolinones | 1 | 2022 | 219 | 0.040 |
Why?
|
Skin | 1 | 1994 | 4499 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 3804 | 0.040 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2003 | 827 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2005 | 1733 | 0.040 |
Why?
|
RANK Ligand | 1 | 2021 | 321 | 0.040 |
Why?
|
Mice, Inbred C3H | 3 | 2008 | 915 | 0.040 |
Why?
|
Mutation | 2 | 2023 | 30213 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2020 | 239 | 0.040 |
Why?
|
Proteinuria | 1 | 2022 | 613 | 0.040 |
Why?
|
Hot Temperature | 1 | 2006 | 1442 | 0.040 |
Why?
|
Lymphocyte Subsets | 2 | 1997 | 313 | 0.040 |
Why?
|
Imidazoles | 1 | 2005 | 1168 | 0.040 |
Why?
|
Promoter Regions, Genetic | 3 | 1996 | 5789 | 0.040 |
Why?
|
Cross Reactions | 1 | 2020 | 826 | 0.040 |
Why?
|
Epigenomics | 1 | 2024 | 959 | 0.040 |
Why?
|
Chemokines | 1 | 2022 | 962 | 0.040 |
Why?
|
Neutrophil Infiltration | 1 | 2021 | 392 | 0.040 |
Why?
|
Genomics | 1 | 2014 | 5923 | 0.040 |
Why?
|
Protein Kinases | 1 | 2005 | 1610 | 0.040 |
Why?
|
Phytohemagglutinins | 1 | 1997 | 164 | 0.040 |
Why?
|
Trinitrobenzenesulfonic Acid | 1 | 1997 | 65 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2022 | 878 | 0.040 |
Why?
|
Osteoclasts | 1 | 2021 | 713 | 0.040 |
Why?
|
Species Specificity | 2 | 1994 | 2413 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2010 | 6214 | 0.040 |
Why?
|
Freund's Adjuvant | 1 | 1997 | 144 | 0.040 |
Why?
|
Macrophage-Activating Factors | 1 | 2017 | 21 | 0.040 |
Why?
|
Immunoglobulin Isotypes | 1 | 1997 | 158 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 3246 | 0.030 |
Why?
|
Base Sequence | 4 | 1996 | 12415 | 0.030 |
Why?
|
Computational Biology | 2 | 2019 | 3564 | 0.030 |
Why?
|
Mice, Nude | 1 | 2003 | 3616 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 1998 | 271 | 0.030 |
Why?
|
Endotoxemia | 1 | 2018 | 198 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6558 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2018 | 740 | 0.030 |
Why?
|
Clone Cells | 3 | 1998 | 1670 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2019 | 526 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 1604 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2019 | 2717 | 0.030 |
Why?
|
Ligation | 1 | 1997 | 446 | 0.030 |
Why?
|
Transcription Factors | 1 | 1996 | 12150 | 0.030 |
Why?
|
Young Adult | 2 | 2021 | 59939 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2020 | 2012 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 803 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 190 | 0.030 |
Why?
|
Cryoelectron Microscopy | 1 | 2020 | 645 | 0.030 |
Why?
|
Ionomycin | 1 | 1996 | 109 | 0.030 |
Why?
|
STAT6 Transcription Factor | 1 | 1996 | 196 | 0.030 |
Why?
|
RNA Ligase (ATP) | 1 | 1995 | 9 | 0.030 |
Why?
|
Ethidium | 1 | 1995 | 27 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2004 | 1429 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 2003 | 13411 | 0.030 |
Why?
|
Mast Cells | 1 | 2003 | 1405 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2021 | 2234 | 0.030 |
Why?
|
DNA, Complementary | 2 | 1997 | 1989 | 0.030 |
Why?
|
Bronchial Hyperreactivity | 2 | 2012 | 299 | 0.030 |
Why?
|
Cholesterol, VLDL | 1 | 2015 | 70 | 0.030 |
Why?
|
Templates, Genetic | 1 | 1995 | 188 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2003 | 1406 | 0.030 |
Why?
|
Interferons | 1 | 2019 | 714 | 0.030 |
Why?
|
Blood Platelets | 1 | 2006 | 2465 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2020 | 1227 | 0.030 |
Why?
|
Apolipoprotein B-100 | 1 | 2015 | 157 | 0.030 |
Why?
|
Immunization | 1 | 1999 | 1218 | 0.030 |
Why?
|
Eosinophilia | 2 | 2015 | 554 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 1352 | 0.030 |
Why?
|
Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 30 | 0.030 |
Why?
|
Child, Preschool | 6 | 2021 | 42577 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 1996 | 252 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 2001 | 1043 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1996 | 826 | 0.030 |
Why?
|
Osteogenesis | 1 | 2021 | 1282 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2005 | 3721 | 0.030 |
Why?
|
Workflow | 1 | 2019 | 859 | 0.030 |
Why?
|
Blotting, Northern | 1 | 1996 | 1550 | 0.030 |
Why?
|
Child | 7 | 2023 | 80668 | 0.030 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2018 | 701 | 0.030 |
Why?
|
Apolipoproteins B | 1 | 2015 | 385 | 0.030 |
Why?
|
Cell Membrane | 1 | 2003 | 3641 | 0.030 |
Why?
|
Antigens, Bacterial | 1 | 1999 | 1148 | 0.030 |
Why?
|
Adipocytes | 1 | 2021 | 1196 | 0.030 |
Why?
|
Cell Line | 4 | 1996 | 15563 | 0.030 |
Why?
|
Reference Values | 2 | 1999 | 4913 | 0.030 |
Why?
|
RNA | 3 | 2005 | 2715 | 0.030 |
Why?
|
Neoplasms | 3 | 2011 | 22350 | 0.030 |
Why?
|
Cadherins | 1 | 2018 | 902 | 0.030 |
Why?
|
Pyridines | 1 | 2005 | 2888 | 0.030 |
Why?
|
Cryopreservation | 1 | 2018 | 727 | 0.030 |
Why?
|
Protein Conformation | 1 | 2020 | 3947 | 0.030 |
Why?
|
Borrelia burgdorferi Group | 1 | 1992 | 95 | 0.030 |
Why?
|
Endothelium | 1 | 1995 | 768 | 0.030 |
Why?
|
Blood Vessels | 1 | 2018 | 1111 | 0.030 |
Why?
|
Granulocytes | 1 | 2014 | 551 | 0.030 |
Why?
|
Toxoplasmosis | 1 | 1993 | 94 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2881 | 0.030 |
Why?
|
3T3 Cells | 1 | 1994 | 1082 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12985 | 0.020 |
Why?
|
Hypotension | 1 | 2018 | 887 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1646 | 0.020 |
Why?
|
Genome, Human | 1 | 2005 | 4443 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3135 | 0.020 |
Why?
|
Bacterial Infections | 1 | 2000 | 1390 | 0.020 |
Why?
|
Antibodies, Protozoan | 1 | 1993 | 251 | 0.020 |
Why?
|
Toxoplasma | 1 | 1993 | 159 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2023 | 3601 | 0.020 |
Why?
|
Genes, T-Cell Receptor | 1 | 2011 | 29 | 0.020 |
Why?
|
Apoptosis | 3 | 2016 | 9513 | 0.020 |
Why?
|
DNA Primers | 1 | 1995 | 2826 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 1997 | 1495 | 0.020 |
Why?
|
Airway Resistance | 1 | 2012 | 407 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5690 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2018 | 6507 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 1600 | 0.020 |
Why?
|
Pyrimidines | 1 | 2023 | 3043 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 54871 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2020 | 2010 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2014 | 1606 | 0.020 |
Why?
|
China | 1 | 2016 | 2383 | 0.020 |
Why?
|
Immunogenetic Phenomena | 1 | 2010 | 23 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 1996 | 5795 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 26310 | 0.020 |
Why?
|
Genes, Mitochondrial | 1 | 2010 | 59 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 1994 | 1030 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3139 | 0.020 |
Why?
|
DNA-Binding Proteins | 3 | 1996 | 9611 | 0.020 |
Why?
|
Kinetics | 2 | 1994 | 6287 | 0.020 |
Why?
|
Genes, Immunoglobulin | 1 | 2010 | 283 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2020 | 17088 | 0.020 |
Why?
|
Infant | 4 | 2021 | 36461 | 0.020 |
Why?
|
Food Additives | 1 | 1989 | 23 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2003 | 3306 | 0.020 |
Why?
|
General Surgery | 1 | 2020 | 1720 | 0.020 |
Why?
|
Aged | 7 | 2021 | 171343 | 0.020 |
Why?
|
Liver | 1 | 2004 | 7571 | 0.020 |
Why?
|
Adolescent | 6 | 2021 | 88904 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9357 | 0.020 |
Why?
|
Escherichia coli | 1 | 2021 | 4211 | 0.020 |
Why?
|
Environment | 1 | 2014 | 1120 | 0.020 |
Why?
|
Stem Cells | 1 | 2021 | 3537 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3957 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2023 | 5329 | 0.020 |
Why?
|
Zymosan | 1 | 2008 | 134 | 0.020 |
Why?
|
Triglycerides | 1 | 2015 | 2441 | 0.020 |
Why?
|
Aorta | 1 | 2015 | 2043 | 0.020 |
Why?
|
Europe | 1 | 2014 | 3430 | 0.020 |
Why?
|
Culture Media | 1 | 1989 | 893 | 0.020 |
Why?
|
Molecular Weight | 1 | 1989 | 2168 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6779 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4427 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2019 | 3691 | 0.020 |
Why?
|
Cell Nucleus | 1 | 1996 | 2870 | 0.020 |
Why?
|
Binding Sites | 1 | 1995 | 6012 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1996 | 2448 | 0.020 |
Why?
|
Trans-Activators | 1 | 1996 | 2855 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3666 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 891 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 474 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 478 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 439 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1989 | 1528 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 2978 | 0.020 |
Why?
|
Superoxides | 1 | 1987 | 388 | 0.020 |
Why?
|
Models, Animal | 1 | 2012 | 2121 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2413 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9602 | 0.010 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 693 | 0.010 |
Why?
|
Phosphorylation | 1 | 1995 | 8307 | 0.010 |
Why?
|
Plaque, Atherosclerotic | 1 | 2016 | 1535 | 0.010 |
Why?
|
Rats | 2 | 1997 | 23717 | 0.010 |
Why?
|
Incidence | 1 | 2022 | 21525 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 2011 | 1145 | 0.010 |
Why?
|
Acute Disease | 1 | 2014 | 7241 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2011 | 1802 | 0.010 |
Why?
|
Genotype | 2 | 2011 | 13036 | 0.010 |
Why?
|
Platelet Count | 1 | 2006 | 784 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2011 | 2730 | 0.010 |
Why?
|
Aging | 1 | 2022 | 8731 | 0.010 |
Why?
|
Microarray Analysis | 1 | 2005 | 751 | 0.010 |
Why?
|
Peritoneal Diseases | 1 | 2003 | 76 | 0.010 |
Why?
|
United States | 2 | 2020 | 72951 | 0.010 |
Why?
|
Principal Component Analysis | 1 | 2005 | 949 | 0.010 |
Why?
|
Abdomen | 1 | 2008 | 1137 | 0.010 |
Why?
|
Occupational Exposure | 1 | 2012 | 1807 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 1993 | 4424 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11872 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 2931 | 0.010 |
Why?
|
Specimen Handling | 1 | 2005 | 706 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 2693 | 0.010 |
Why?
|
Asthma | 1 | 1998 | 6268 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15835 | 0.010 |
Why?
|
Peptides | 1 | 2011 | 4344 | 0.010 |
Why?
|
Methacholine Chloride | 1 | 1998 | 219 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2010 | 8540 | 0.010 |
Why?
|
HLA-DQ Antigens | 1 | 1998 | 190 | 0.010 |
Why?
|
Proteins | 1 | 1992 | 6002 | 0.010 |
Why?
|
Age Factors | 2 | 2010 | 18397 | 0.010 |
Why?
|
Immunoglobulin Variable Region | 1 | 1998 | 419 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 1975 | 5887 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59550 | 0.010 |
Why?
|
Software | 1 | 2010 | 4466 | 0.010 |
Why?
|
Models, Statistical | 1 | 2010 | 5091 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 1997 | 1168 | 0.010 |
Why?
|
Deoxyribonucleoproteins | 1 | 1994 | 3 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 1999 | 13485 | 0.010 |
Why?
|
CHO Cells | 1 | 1997 | 1376 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2003 | 4860 | 0.010 |
Why?
|
Ischemia | 1 | 2003 | 1905 | 0.010 |
Why?
|
Mice, Inbred AKR | 1 | 1993 | 103 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 14762 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1994 | 766 | 0.010 |
Why?
|
Cricetinae | 1 | 1997 | 2416 | 0.010 |
Why?
|
Brain | 1 | 2020 | 27159 | 0.010 |
Why?
|
Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1993 | 67 | 0.010 |
Why?
|
Eyeglasses | 1 | 1954 | 138 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39309 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1997 | 2746 | 0.010 |
Why?
|
Patient Selection | 1 | 2005 | 4252 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1997 | 2177 | 0.010 |
Why?
|
Azacitidine | 1 | 1994 | 335 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 1993 | 439 | 0.010 |
Why?
|
Methylation | 1 | 1994 | 1074 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1997 | 4168 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 65273 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1995 | 1131 | 0.010 |
Why?
|
Viscera | 1 | 1951 | 138 | 0.010 |
Why?
|
Adrenal Cortex | 1 | 1951 | 134 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1994 | 792 | 0.010 |
Why?
|
Thyroid Function Tests | 1 | 1951 | 289 | 0.010 |
Why?
|
Genes | 1 | 1994 | 1824 | 0.010 |
Why?
|
Cyclosporine | 1 | 1993 | 778 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20708 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14652 | 0.010 |
Why?
|
Israel | 1 | 1993 | 726 | 0.010 |
Why?
|
Emigration and Immigration | 1 | 1993 | 405 | 0.010 |
Why?
|
Graft Rejection | 1 | 2003 | 4504 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 29948 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1993 | 2470 | 0.010 |
Why?
|
Immunotherapy, Adoptive | 1 | 1999 | 1504 | 0.010 |
Why?
|
Mutagenesis | 1 | 1993 | 1228 | 0.000 |
Why?
|
Organ Specificity | 1 | 1993 | 1966 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2005 | 20144 | 0.000 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1954 | 2205 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1999 | 11061 | 0.000 |
Why?
|
Bacteria | 1 | 1996 | 2212 | 0.000 |
Why?
|
Thyroid Gland | 1 | 1951 | 1170 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1996 | 10745 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 1989 | 15657 | 0.000 |
Why?
|
Rural Population | 1 | 1993 | 2321 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 1993 | 7841 | 0.000 |
Why?
|
Sex Factors | 1 | 1993 | 10619 | 0.000 |
Why?
|